The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma.
- Published in:
- Frontiers in Genetics, 2021, v. 11, p. N.PAG, doi. 10.3389/fgene.2020.583085
- By:
- Publication type:
- Article
Works matching AU Mo, Jun-Xian
Results: 5
1
2
Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance.
- Published in:
- FEBS Open Bio, 2021, v. 11, n. 11, p. 3126, doi. 10.1002/2211-5463.13306
- By:
- Publication type:
- Article
3
Esophagectomy versus definitive chemoradiotherapy as initial treatment for clinical stage I esophageal cancer: a systematic review and meta-analysis.
- Published in:
- Diseases of the Esophagus, 2022, v. 35, n. 3, p. 1, doi. 10.1093/dote/doab049
- By:
- Publication type:
- Article
4
Early versus the traditional start of oral intake following esophagectomy for esophageal cancer: a systematic review and meta-analysis.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 4, p. 3473, doi. 10.1007/s00520-022-06813-0
- By:
- Publication type:
- Article
5
Integrated expression analysis revealed RUNX2 upregulation in lung squamous cell carcinoma tissues.
- Published in:
- IET Systems Biology (Wiley-Blackwell), 2020, v. 14, n. 5, p. 252, doi. 10.1049/iet-syb.2020.0063
- By:
- Publication type:
- Article